Publications by authors named "Matteo Leoncin"

Claim this Profile
P
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.
Davide Lazzarotto, Anna Maria Testi, Matteo Fanin, Federico Mosna, Sabina Chiaretti, Matteo Leoncin

Ann Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 study.
Renato Bassan, Sabina Chiaretti, Irene Della Starza, Alessandra Santoro, Orietta Spinelli, Matteo Leoncin

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.
Davide Lazzarotto, Marco Cerrano, Cristina Papayannidis, Sabina Chiaretti, Federico Mosna, Matteo Leoncin

Haematologica· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience.
Francesco Angotzi, Federica Lessi, Matteo Leoncin, Carla Filì, Mauro Endri

Front Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
Davide Lazzarotto, Ilaria Tanasi, Antonella Vitale, Matteo Piccini, Michelina Dargenio, Matteo Leoncin

Ann Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine.
Matteo Leoncin, Roberta La Starza, Giovanni Roti, Luca Pagliaro, Renato Bassan

Curr Opin Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group.
Marzia Defina, Davide Lazzarotto, Fabio Guolo, Paola Minetto, Nicola Stefano Fracchiolla, Matteo Leoncin

Leuk Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience" [Leukemia Res. 114 (March 2022) 106803].
Eleonora De Bellis, Silvia Imbergamo, Anna Candoni, Albana Liço, Ilaria Tanasi, Matteo Leoncin

Leuk Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience.
Eleonora De Bellis, Silvia Imbergamo, Anna Candoni, Albana Liço, Ilaria Tanasi, Matteo Leoncin

Leuk Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous positive myeloid sarcoma and acute B-lymphoblastic leukemia.
Giuliana Rizzuto, Matteo Leoncin, Silvia Imbergamo, Daniela Taurino, Maria Caterina Mico

Clin Case Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoblastic Lymphoma: a Concise Review.
Tamara Intermesoli, Alessandra Weber, Matteo Leoncin, Luca Frison, Cristina Skert

Curr Oncol Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL.
Manuela Tosi, Orietta Spinelli, Matteo Leoncin, Roberta Cavagna, Chiara Pavoni

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large Granular Lymphocyte Leukemia and Precapillary Pulmonary Hypertension.
Brieuc Cherel, Marc Humbert, Francis R LeBlanc, Renato Zambello, Mohamed Hamidou, Matteo Leoncin

Chest· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a -Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemia.
Barbara Mariotti, Giulia Calabretto, Marzia Rossato, Antonella Teramo, Monica Castellucci, Matteo Leoncin

Haematologica· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients.
Gregorio Barilà, Antonella Teramo, Giulia Calabretto, Cristina Vicenzetto, Vanessa Rebecca Gasparini, Matteo Leoncin

Leukemia· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation.
Gregorio Barilà, Antonella Teramo, Giulia Calabretto, Chiara Ercolin, Elisa Boscaro, Matteo Leoncin

Blood Cancer J· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutation impacts biological and clinical features of T-LGL leukemia.
Antonella Teramo, Gregorio Barilà, Giulia Calabretto, Chiara Ercolin, Thierry Lamy, Matteo Leoncin

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis